Loading headlines…

Collected headline brief
MANILA, Philippines — The proposed new generation anti-dengue vaccine remains under review by the Food and Drug Administration (FDA) three years after it applied for registration, according to Malacañang. Citing a statement from the…
Complete reading on newsGlobal
Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →There is more to this story